TY - JOUR
T1 - Deficiency of caspase recruitment domain family, member 11 (CARD11), causes profound combined immunodeficiency in human subjects
AU - Stepensky, Polina
AU - Keller, Baerbel
AU - Buchta, Mary
AU - Kienzler, Anne Kathrin
AU - Elpeleg, Orly
AU - Somech, Raz
AU - Cohen, Sivan
AU - Shachar, Idit
AU - Miosge, Lisa A.
AU - Schlesier, Michael
AU - Fuchs, Ilka
AU - Enders, Anselm
AU - Eibel, Hermann
AU - Grimbacher, Bodo
AU - Warnatz, Klaus
N1 - Deutsche Forschungsgemeinschaft [SFB 620]; Federal Ministry of Education and Research [BMBF 01 EO0803]; Dahlia Greidinger Cancer Research Fund; Clive and Vera Ramaciotti Foundation; NHMRC [APP1035858]; Bundesministerium fur Bildung und Forschung (BMBF); Federal Ministry of Education and Research; BMBF; Baxter; GlaxoSmithKline; CSL Behring; PfizerSupported by Deutsche Forschungsgemeinschaft Grant SFB 620 (to K. W.) and by the Federal Ministry of Education and Research (BMBF 01 EO0803, to K. W., H. E., and B. G.). P. S. was supported by a Dahlia Greidinger Cancer Research Fund. A. E. was supported by a Major Initiative Award from the Clive and Vera Ramaciotti Foundation and a Career Development Fellowship from the NHMRC (APP1035858).B. Keller has received grants from Bundesministerium fur Bildung und Forschung (BMBF). B. Grimbacher has received grants from the Federal Ministry of Education and Research. K. Warnatz has received grants from BMBF and Baxter, and has received payment for lectures, including service on speakers' bureaus, from Baxter, GlaxoSmithKline, CSL Behring, and Pfizer. I. Fuchs has received grants from BMBF. The rest of the authors declare that they have no relevant conflicts of interest.
PY - 2013/2
Y1 - 2013/2
N2 - Background: Profound combined immunodeficiency can present with normal numbers of T and B cells, and therefore the functional defect of the cellular and humoral immune response is often not recognized until the first severe clinical manifestation. Here we report a patient of consanguineous descent presenting at 13 months of age with hypogammaglobulinemia, Pneumocystis jirovecii pneumonia, and a suggestive family history. Objective: We sought to identify the genetic alteration in a patient with combined immunodeficiency and characterize human caspase recruitment domain family, member 11 (CARD11), deficiency. Methods: Molecular, immunologic, and functional assays were performed. Results: The immunologic characterization revealed only subtle changes in the T-cell and natural killer cell compartment, whereas B-cell differentiation, although normal in number, was distinctively blocked at the transitional stage. Genetic evaluation revealed a homozygous deletion of exon 21 in CARD11 as the underlying defect. This deletion abrogated protein expression and activation of the canonical nuclear factor κB (NF-κB) pathway in lymphocytes after antigen receptor or phorbol 12-myristate 13-acetate stimulation, whereas CD40 signaling in B cells was preserved. The abrogated activation of the canonical NF-κB pathway was associated with severely impaired upregulation of inducible T-cell costimulator, OX40, cytokine production, proliferation of T cells, and B cell-activating factor receptor expression on B cells. Conclusion: Thus in patients with CARD11 deficiency, the combination of impaired activation and especially upregulation of inducible T-cell costimulator on T cells, together with severely disturbed peripheral B-cell differentiation, apparently leads to a defective T-cell/B-cell cooperation and probably germinal center formation and clinically results in severe immunodeficiency. This report discloses the crucial and nonredundant role of canonical NF-κB activation and specifically CARD11 in the antigen-specific immune response in human subjects.
AB - Background: Profound combined immunodeficiency can present with normal numbers of T and B cells, and therefore the functional defect of the cellular and humoral immune response is often not recognized until the first severe clinical manifestation. Here we report a patient of consanguineous descent presenting at 13 months of age with hypogammaglobulinemia, Pneumocystis jirovecii pneumonia, and a suggestive family history. Objective: We sought to identify the genetic alteration in a patient with combined immunodeficiency and characterize human caspase recruitment domain family, member 11 (CARD11), deficiency. Methods: Molecular, immunologic, and functional assays were performed. Results: The immunologic characterization revealed only subtle changes in the T-cell and natural killer cell compartment, whereas B-cell differentiation, although normal in number, was distinctively blocked at the transitional stage. Genetic evaluation revealed a homozygous deletion of exon 21 in CARD11 as the underlying defect. This deletion abrogated protein expression and activation of the canonical nuclear factor κB (NF-κB) pathway in lymphocytes after antigen receptor or phorbol 12-myristate 13-acetate stimulation, whereas CD40 signaling in B cells was preserved. The abrogated activation of the canonical NF-κB pathway was associated with severely impaired upregulation of inducible T-cell costimulator, OX40, cytokine production, proliferation of T cells, and B cell-activating factor receptor expression on B cells. Conclusion: Thus in patients with CARD11 deficiency, the combination of impaired activation and especially upregulation of inducible T-cell costimulator on T cells, together with severely disturbed peripheral B-cell differentiation, apparently leads to a defective T-cell/B-cell cooperation and probably germinal center formation and clinically results in severe immunodeficiency. This report discloses the crucial and nonredundant role of canonical NF-κB activation and specifically CARD11 in the antigen-specific immune response in human subjects.
KW - B cell-activating factor receptor
KW - CARD11
KW - combined immunodeficiency
KW - germinal center
KW - human
KW - hypogammaglobulinemia
KW - inducible T-cell costimulator
KW - nuclear factor κB
KW - profound combined immunodeficiency disorder
KW - transitional B cell
UR - http://www.scopus.com/inward/record.url?scp=84873348862&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.jaci.2012.11.050
DO - https://doi.org/10.1016/j.jaci.2012.11.050
M3 - مقالة
SN - 0091-6749
VL - 131
SP - 477-485.e1
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 2
ER -